Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like 3 Digital Transformation Mistakes Manufacturers Make – and How to Avoid Them September 26, 2018 3D Systems and Antleron Partner to Create Biomedical Solutions November 14, 2019 Siemens and juwi announce partnership to focus on microgrids in mining November 15, 2019